期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠状动脉介入治疗无复流现象的治疗进展

Therapeutic Progresses of No-reflow Phenomenon after Percutaneous Coronary Interventions
暂未订购
导出
摘要 急性心肌梗死行冠状动脉介入治疗后,无复流现象的发生导致心肌梗死的延展、心功能恢复障碍、左室重构等合并症,严重影响了介入治疗的效果。因此,改善心肌微循环再灌注,减少无复流现象的发生率成为当今冠状动脉介入治疗的新热点。本文就无复流现象的治疗现状予以综述。 After percutaneous coronary interventions in patients with acute myocardial infarction, the incidence of no-reflow phenomenon will result in some complications including increased infarction, disorder of heart functional recovery and left ventricular remodeling, which can result in the efficacy of interventional therapy. So, it is the hot spot in coronary interventional therapy to improve reperfusion of myocardial microcirculation, reduce the incidence rate of no-flow phenomenon. This article reviews therapeutic progresses of noreflow phenomenon.
作者 凌政
机构地区 玉林市第一人民医院心内科
出处 《医学综述》 2008年第16期2517-2520,共4页 Medical Recapitulate
关键词 急性心肌梗死 无复流现象 微循环 经皮冠状动脉介入治疗 Acute myocardial infarction No-reflow phenomenon Microcirculation Percutaneous coronary interventional therapy
分类号 R542.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献25

  • 1Wilson RF, Lasson DD, Lesser JR,et al. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions [ J ]. Lancet, 1989,1 (8642) : 807-811.
  • 2Falk E, Thuesen L. Pathology of coronary microembolisation and no reflow [ J ]. Heart, 2003,89 (9) : 983 -985.
  • 3Piana RN, Paik GY, Moscucci M. Incidence and treatment of ‘no-reflow' after percutaneous coronary intervention [ J ]. Circulation, 1994,89(6) :2514-2518.
  • 4Watanabe T, Nanto S, Uematsu M, et al. Prediction of no-reflow phenomenon after successful percutaneous coronary intervention in patients with acute myocardial infarction: intravascular ultrasound findings [ J]. Circ J,2003,67 ( 8 ) :667-671.
  • 5Antoniucci D, Valenti R, Migliorini A, et al. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction[J]. Am Heart J,2001,142(4) :684-690.
  • 6Mofishima J, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[ J ]. J Am Coll Cardiol,2000,36 (4) : 1202-1209.
  • 7Resnic FS,Wainstein M,Lee MK,et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[ J]. Am Heart J,2003,145 (1) :42-46.
  • 8夏菁.冠脉无复流现象治疗的研究进展[J].现代诊断与治疗,2005,16(5):292-294. 被引量：2
  • 9Cohen DJ, Murphy SA, Baim DS, et al. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts : results from the SAFER trial[J]. J Am Coll Cardiol ,2004 ,44 (9) :1801-1808.
  • 10Stone GW, Rogers C, Hermiller J ,et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts[ J]. Circulation,2003, 108 (5) :548-553.

二级参考文献16

  • 1Resnic FS,Wainstein M,Lee MK,et al.No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[J].Am Heart J,2003,145:42-46.
  • 2Gawaz M.Role of platelets in coronary thrombosis and reperfusion of ischemic myocardiam[J].Cardiovasc Res,2004,61:498-511.
  • 3Kotani J,Mintz GS,Pregowski J,et al.Volumetric intravascular ultrasound evidence that distal embolization during acute infarct intervention contributes to inadequate myocardial perfusion grade[J].Am J Cardiol,2003,92:728-732.
  • 4Reffelmann T,Kloner RA.Effects of adenosine and verapamil on anatomic no-reflow in a rabbit model of coronary artery occlusion and reperfusion[J].J Cardiovasc Pharmacol,2004,43(4):580-588.
  • 5Eltzschig HK,Thompson LF,Karhausen J,et al.Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation:coordination by extracellular nucleotide metabolism[J].Blood,2004,104,3986-3992.
  • 6Mahaffey KW,Puma JA,Barbagelata NA,et al.Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter,randomized,placebo-controlled trial:the acute myocardial infarction study of adenosine(AMISTAD) trial[J].J Am Coll Cardiol,1999,34(6):1711-1720.
  • 7Quintana M,Hjemdahl P,Sollevi A,et al.Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis,results of the attenuation by adenosine of cardiac complications(ATTACC) study[J].Eur J Clin Pharmacol,2003,59(1):1-9.
  • 8Mario M,Enrico O,Paoleto M,et al.Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction[J].Circulation,2000,101:2154-2159.
  • 9Schwarz M,Nordt T,Bode C,et al.The GP Ⅱb/Ⅲa inhibitor abciximab(c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1(CD11b/CD18,alphaMbeta2)[J].Thromb Res,2002,107:121-128.
  • 10Moliterno DJ,Chan AW.Glycoprotein Ⅱb/Ⅲa inhibition in early intent-to-stent treatment of acute coronary syndromes:EPISTENT,ADMIRAL,CADILLAC,and TARGET[J].J Am Coll Cardiol,2003,41:49-54.

共引文献1

医学综述
2008年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部